BUZZ-Kenvue tumbles after report RFK Jr. links autism risk in tylenol use

Reuters
2025.09.05 18:10
portai
I'm PortAI, I can summarize articles.

Shares of Kenvuefell 10% to $18.46 following a report that Health Secretary Robert F. Kennedy Jr. will release a government report linking Tylenol use during pregnancy to autism. Kenvue, which produces Tylenol, maintains that there is no causal link between acetaminophen use and autism. The stock is down 12% year-to-date.

Shares of consumer healthcare co Kenvue (KVUE.N) fall 10% to $18.46

U.S. Health Secretary Robert F. Kennedy Jr. plans to release government report linking Tylenol use during pregnancy to autism, The Wall Street Journal reports, citing people familiar with matter

Tylenol, whose active ingredient is acetaminophen, is made by Kenvue and is widely used for pain relief, including by pregnant women

Report will also suggest medicine derived from folate, called folinic acid, can be used to treat symptoms of the disorder in some people, WSJ adds

Speaking on WSJ report, Kenvue says it continues to believe there is no causal link between acetaminophen use during pregnancy and autism, CNBC reports

Including session’s moves, stock down 12% YTD

Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.